Deal Announcement: Labomar

Type of deal: Acquisition of Pharmia Holding Oy

Sector: Healthcare industry

PwC Finland, together with PwC Italy, acted as legal advisor to Labomar, owned by Charterhouse Capital Partners, in its acquisition of a majority stake in Pharmia Holding Oy. Pharmia is the leading Finnish contract manufacturer of food supplements and CE-marked medical devices in the Nordic region, employing around 85 people and generating an annual turnover of approximately 20 million euros.

The strategic acquisition of Pharmia Holding Oy will enable Labomar to further expand its research and development capabilities, particularly in medical devices and probiotics, and to benefit from a strong position in a high-potential geographic area.

Deal announcement date: 2 October 2025

PwC's role: Legal advisor

Press release